BQ 788
Alternative Names: BQ788Latest Information Update: 24 Oct 2021
At a glance
- Originator Banyu
- Class
- Mechanism of Action Endothelin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 08 Aug 2002 Discontinued - Preclinical for Hypertension in USA (unspecified route)
- 10 Feb 2000 Preclinical trials in Hypertension in USA (unspecified route)